by AYUR
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
DAUNORUBICIN-20MG
Uses:
lymphocytic leukemia, Acute non-lymphocytic leukemia
Medicinal Benefits:
Daunoplus 20Mg Inj contains Daunorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis. Thus, Daunoplus 20Mg Inj stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes the death of cells.
Daunoplus 20Mg Inj contains Daunorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis.
Daunoplus 20Mg Inj may cause embryo-fetal toxicity. Therefore, please consult a doctor before taking Daunoplus 20Mg Inj if you are planning to become a parent.
If you are about to receive any vaccinations, especially live vaccines such as measles, mumps, rubella and polio vaccines, it is advised to inform your doctor that you are on treatment with Daunoplus 20Mg Inj as it may cause infections.